Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Science (New York, N.Y.)|August 26, 1994
MHC class I expression in mice lacking the proteasome subunit LMP-7H J Fehling, W Swat, C Laplace, et al.
Journal of Cardiovascular Pharmacology|April 29, 1998
SR142948A is a potent antagonist of the cardiovascular effects of neurotensinP Schaeffer, M C Laplace, A Bernat, et al.
European Journal of Pharmacology|April 4, 1997
Neurotensin induces the release of prostacyclin from human umbilical vein endothelial cells in vitro and increases plasma prostacyclin levels in the ratP Schaeffer, M C Laplace, V Prabonnaud, et al.
Gynecologie, Obstetrique & Fertilite|April 29, 2000
[Hormone replacement therapy after endometrial or ovarian cancer]E Daraï, A Gompel, B Deval, et al.
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|January 1, 1991
[Value of the combination of propofol-alfentanil and vecuronium for the anesthesia of laparoscopy in ambulatory patients]G Bagou, M C Laplace, B Coronel, et al.
Biochemical Pharmacology|September 15, 1994
Malformin-A1 inhibits the binding of interleukin-1 beta (IL1 beta) and suppresses the expression of tissue factor in human endothelial cells and monocytesJ M Herbert, P Savi, A Lalé, et al.
FEBS Letters|August 16, 1993
IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytesJ M Herbert, P Savi, M C Laplace, et al.
Immunity|June 1, 1997
Restoration of thymopoiesis in pT alpha-/- mice by anti-CD3epsilon antibody treatment or with transgenes encoding activated Lck or tailless pT alphaH J Fehling, B M Iritani, A Krotkova, et al.
Biomedical Optics Express|October 19, 2023
Real-time <i>in vivo</i> ROS monitoring with luminescent nanoparticles reveals skin inflammation dynamicsM Abdesselem, N Pétri, R Kuhner, et al.
European Journal of Pharmacology|June 14, 2000
Characterisation of the effects of SR146131, a novel non-peptide CCK(1) receptor agonist, on IMR-32 human neuroblastoma cellsP Schaeffer, A L Nestor, V Prabonnaud, et al.
Pageof 6